QualificationsM.D., University of Chicago, 1981. Ph.D., University of Chicago, 1981. B.S., Syracuse University, 1974. Expertise and Research InterestsImplantation Research: Implantation is a major hurdle for successful human reproduction. During most attempts of assisted reproductive technology (ART), fewer than 10% of embryos successfully implant. Abnormalities in the process of implantation may underlie infertility in many women, and undermine the effectiveness of ART. Predictors of implantation potential are needed, both to better understand the causes of infertility in women and to improve the efficacy and reliability of embryo transfer. Despite almost two decades of ART, the precise molecular mediators of human implantation remain unknown. As a corollary to this problem, no molecular markers exist to adequately predict whether implantation will occur during any given ART cycle. My research team hypothesized that the dynamic changes in the endometrium throughout the menstrual cycle require the coordinated expression of specific steroid-modulated molecules. Recently we have identified an epitope on MUC1, the major endometrial mucin, which varies throughout the menstrual cycle. This epitope was first identified in endometrial epithelial cell Golgi because of its strong reactivity with IgG antibodies in numerous murine ascites, hence the designation MAG (mouse ascites Golgi). In donor oocyte recipients, MAG appears on the endometrial surface at the time of embryo transfer in women who ultimately become pregnant, but is absent in donor recipients who fail repeatedly to become pregnant. We have also demonstrated that cyclin E and p27 parallel the normal and abnormal expression of MAG in endometrial biopsies. We are investigating MAG, cyclin E and p27 as markers of endometrial receptivity in order to differentiate implantation-receptive endometrium from non-receptive endometrium in donor oocyte andunexplained infertility patients. The results of these studies should provide new information about the significance of MAG mucin/MUC1, cyclin E and p27 expression in clinical settings where high rates of normal implantation are desired. Placental Responseto Inflammation: It is well known that more than a third of all preterm births are associated with labor initiated by acute chorioamnionitis. Not only does chorioamnionitis have severe consequences for the fetus through the initiation of pretermdelivery, but chorioamnionitis is followed by a 20% greater-than-expected frequency of neurologic abnormalities at 7 years of age. Chorioamnionitis appears to be deleterious to the fetus because the inflammatory process induces villous edema. We have hypothesizedthat villous edema makes the fetus hypoxic by compressing fetal blood vessels inside the villi and by increasing the diffusion barrier for oxygen between the maternal and fetal circulations. Our laboratory is developing methods to assess the presence andtiming of villous edema—both pre- and postpartum—and the cytokines responsible for formation of villous edema. Structural Defects in the Placenta Suggest the Presence of Genetic Defects in the Fetus: The placenta grows much like a tree. Just as tree growth patterns can be mathematically modeled using fractal equations, the placenta also follows a simple algorithm for its growth. The cellular basis of the placental growth pattern is the dynamic relationship between cytotrophoblast replication and differentiation towards syncytiotrophoblast. We have identified an abnormal growth pattern of the trophoblast layers which appears to be associated with genetic defects in the fetus: trophoblast invaginations. We are collecting histologic datafrom elective andspontaneous terminations, genetic analysis and ultrasound studies to elucidate the correlation between placental structural abnormalities and genetic defects. Other ExpertiseI wish to be contacted by interested students (medical, graduate or undergraduates) as a potential research mentor/thesis advisor. Academic Experience: Awards, Honors and Membership in Honorary Societies: 1971-74 Regents Scholarship Award, New York State 1971-74 Honors Department, Syracuse University 1974 Graduated Summa Cum Laude (Biology), Syracuse University 1974 Phi Beta Kappa Election 1974 Phi Kappa Phi Honor Society Election 1975-81 Insurance Medical Scientist Scholar 1980 Sigma XiElection 1984 Special Citation, Microscopic Category, ASCP/Kodak Medical Photography Competition. 1985-6 Clinical Research Grant, Diabetes Research and Education Foundation 1985-88 Clinical Investigator Award, NICHD, NIA 1988-9 McCabe Award 1989-90 University Research Foundation Award 1990-1 Medical Center and University BRSG Awards 1991-2 Andrew Mellon Fellowship Award 1993-5 Shannon Award, NICHD, NIH Principal Investigator of Grants: 1. Steroidogenesis in the human trophoblast. NIH 1 KO8 HD00715-01, 12/85-12/88, $187,000 2. Clinical Research Grant, Diabetes Research and Education Foundation, 1985-6, $10,000 3. McCabe Award, 9/88-9/89, $15,000 4. University Research Foundation Award, 7/89-6/90, $7,000 5. Medical Center BRSG Award, 7/90-6/91, $10,000 6. University BRSG Award, 7/90-6/91, $8,000 7. TUN: Purification and Characterization, Ares-Serono, 12/91-11/93, $67,000 8. MAG: MAG Mucin, Abbott Laboratories, 4/92-93, $15,000 9. Leukocyte chemoattractants in endometriosis, 1R55HD30501-01A1, 9/30/93-9/29/95, $100,000 10. MAG Mucin Diagnostic, Centocor, Inc., 7/1/95-6/30/96, $46,150 11. MAG Mucin and Endometrial Receptivity, 12/01/96-01/31/00, NICHD, $793,498, pending Study Sections: Biochemical Endocrinology (AHR-M1) Study Section, 11/92 Reproductive Endocrinology (AHR-B1) Study Section, 3/94 Reproductive Endocrinology (AHR-B1) Study Section, 7/94 Division of Scientific Review, NICHD, Site Visit, 4/96 Academic Committees at the University of Pennsylvania: 1984-91 Member, Tissue Committee 1986 Member, Endocrinology Curriculum Review Committee 1987-91 Member, Committee on Studies Involving Human Beings 1988-90 Member, Computers in Medical Education 1990-91 Chairman, Education Subcommittee of the University Information Resource Management Committee Academic Committees at Yale University: 1993-95 Member, Library Committee, School of Medicine 1993-95 Member, Committee on Computers in Medical Education Search Committees at Yale University: 1992 Member, Search for Director, Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology 1992 Member, Search for Director, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology 1992-3 Member, Pathology Residents Recruitment Committee Community Activities: 1991- Member, Board of Education, B'nai Jacob, Woodbridge 1993- Member, Publicity Committee, B'nai Jacob, Woodbridge 1995- Presidential Couple, Connecticut Jewish Marriage Encounter Teaching and Clinical Responsibilities at Yale University: Perinatal/Placental Pathology Activities: Placental and Perinatal Pathology Program Director, 1991-95 Perinatal-Placental Review Conference (weekly), 1991-95 Reproductive Endocrinology Review Conference (weekly), 1991-95 Ob/Gyn Resident Pathology Review Series (biweekly), 1991-95 Perinatal Morbidity and Mortality Conference (monthly), 1991-95 Maternal-Fetal Medicine Lecture Series (biannual), 1991-95 Norwalk/Danbury Teaching Lectures (annual), 1991- Medical Center Teaching: Pathology Residents: Gestational Pathology (daily), 1991-95 Pathology Residents: Perinatal Autopsy Service (daily), 1991-95 Quinnipiac College Pathologists' Assistant Program Instructor (daily), 1991-95 Pathology 100 Laboratory Instructor, 1991-95 Pathology 100 Tutorial Leader, 1991-95 Pathology of Placenta and Fetus, Pathology 100, 1991- Implantation and Placenta Formation, Reproductive Biology 280b, 1991- Ob/Gyn 3rd year Clerkship, Reproductive BiologyCourse (6 times/y), 1991- Graduate Students, Fellows, Medical and Undergraduate Trainees: Graduate Students: L-C Kao, Department of Pathology, University of Pennsylvania, ''Trophoblast Interactions with Extracellular Matrix Proteins''; S Caltabiano, Department of Obstetrics and Gynecology, University of Pennsylvania, ''Role of GnRH in Trophoblast hCG Synthesis and Secretion'' Medical Fellows: MA Feinman, Department of Obstetrics and Gynecology, University of Pennsylvania, ''Role of cAMP in Trophoblast Differentiation''; L Schwartz, Department of Obstetrics and Gynecology, Yale School of Medicine, ''Mouse Ascites Golgi (MAG) Mucin Expression And Regulation By Progesterone In The Rat''; M Cunningham, Department of Surgery, Yale School of Medicine, ''Interleukin-8 Secretion by Trophoblasts in Response to Endotoxin''; M Nachtigall, Department of Obstetrics and Gynecology, Yale School of Medicine, ''Role of Leukemia Inhibitory Factor in Trophoblast Differentiation and Implantation''; Tony Asis, Department of Obstetrics and Gynecology, Yale School of Medicine, ''EPO and CRH Expression in Normal and Stressed Placentas'' Post-Doctoral Fellows: R Feinberg, Department of Obstetrics and Gynecology, University of Pennsylvania, ''Plasminogen Activator Inhibitor Expression in Invading Trophoblasts'' X Li, Department of Obstetrics and Gynecology, Korea, ''Degradation Pathways of hCG in the Chorionic Villous'' K-S Lee, Department of Obstetrics and Gynecology, Pusan National University, Korea, ''Degradation Pathways of hCG in the Chorionic Villous Core'' Senior Medical Thesis Advisor: E Buchanan, Medical Student Research Fellow of the American Heart Association, Department of Pathology, University of Pennsylvania, ''Urokinase Receptor: A Modulatorfor Trophoblast Invasion?'' Undergraduate Senior Thesis Advisor: S Wu, Department of Obstetrics and Gynecology, University of Pennsylvania, ''Effect of ECM on Trophoblast Endocrine Function''; K Ahn, Yale College, Yale University, ''Identification of Endometrial Tissue in Menstrual and Peritoneal Fluid: Precursor for Endometriosis?'' Summer Student Advisor: J Wetmore, Yale College, Yale University, ''Endometrial MAG Mucin Expression in Normal and Infertile Patients''; L Gordon, Yale College, Yale University, ''Endometrial Receptivity and MAG Mucin Expression'' Reviewer of Manuscripts for the following Journals: American Journal of Obstetrics and Gynecology American Journal of Pathology Biology of Reproduction Cancer Research Development Developmental Biology In Vitro Journal of Clinical Investigation Journal of Developmental Physiology Laboratory Investigation Placenta Trophoblast Research International Workshops Organized October 10, 1988 ''Trophoblast Differentiation in Tissue Culture,'' 11th Rochester Trophoblast Conference, Rochester, NY; September 28, 1989 ''Trophoblast Cells in Culture,'' III European Placental Group Meeting, Paris, France; October 2, 1992 ''Models of Implantation: Trophoblast Endometrium Interactions,'' 12th Rochester Trophoblast Conference, KeywordsCOS Keywords:Embryology, Human Reproduction Or Fertility, Implants, Infertility, Placenta, Pregnancy.Additional Terms:Endometrium, Infertility, Placenta, Pregnancy.Languages(Reading, Writing, Speaking)Hebrew: (Basic, Basic, Basic) MembershipsAmerican Society for Cell Biology American Society of Clinical Pathologists American Society of Reproductive Medicine Canadian Academy of Pathologists European Trophoblast Group Sigma Xi, The Scientific Research Society Society for Maternal-Fetal Medicine Society of Gynecological Investigation United States Academy of Pathologists Previous PositionsFellow, University of Pennsylvania 1981-1985, Hospital of the University of Pennsylvania, Resident, Pathology 1985-1987, University of Pennsylvania, Research Associate 1987-1991, University of Pennsylvania, Assistant Professor 1991-1995, Yale University, Assistant Professor PatentsMethods of diagnosing and monitoring endometrial glandular development,
Patent Number: 6733962,
2004,
United States of America.
![]() Fertility Determination with Transforming Growth Factor Beta,
Patent Number: 676727,
1998,
University of Pennsylvani,
Australia.
Fertility Determination with Transforming Growth Factor Beta,
Patent Number: 5693479,
1997,
Institution-owned,
United States of America.
![]() Therapeutic and Diagnostic Applications of Mouse Ascites Golgi (MAG) Manipulation,
Patent Number: 5599680,
1997,
University of Pennsylvani,
United States.
![]() Therapeutic and Diagnostic Applications of Tropho-Uteronectin (TUN) Manipulation, U.S. Patent No. 5,276,017, 90/94, institution-owned Fertility Regulation with Transforming Growth Factor Beta, U.S. Patent No. 5,395,825, 92/95, institution-owned Antibodies Specific for Oncofetal Fibronectin, U.S. Patent No. 5,523,229, 93/96, institution-owned Funding Received
Publications
Profile DetailsLast Updated: 9/27/2005 COS Expertise ID #1206674 Reference this profile directly: http://myprofile.cos.com/klimanh16 Individual Expertise profile of Harvey J. Kliman, Copyright Harvey J. Kliman. © COS ExpertiseTM, 2009, ProQuest LLC All rights reserved. |